October 2006 Issue
At a time when the amount of available data is increasing exponentially, why are we isolating ourselves from our brethren and the larger scientific community?
When will pharma's Lean index catch up with its "Mean" index?
Dr. Swati Piramal has put one of Indias leading drug companies, and a family business, on a global stage
As pill-cutting becomes the dispensing norm, improperly designed or nonfunctional tablet bisects could pose liability issues
We spotlight the winners of Pharmaceutical Manufacturing's 2006 Team of the Year Award and encourage drugmaking professionals to nominate equally excellent teams for the 2007 Award.
FDAs pedigree requirements are sparking debate among drug manufacturers. Among the sticking points: the definition of ADRs, as well as a proposal to base pedigree lists on past counterfeiting cases.
Pharmas capital spending budgets are up, but the rules of the game are changing. Outsourcing will play a more prominent role than ever before.
At Purdue University, Professor Jim McGlothlin and his research team are perfecting an inexpensive, yet powerful way to track emissions and operators performance.
Critical to improving performance and extending patent life, drug delivery is the only area where the small often trump megapharmas
When a high-potency compound needed a new home, Schering-Plough took containment to the extreme at its Las Piedras, Puerto Rico site.
A team at the University of Saskatchewan is applying tomography to the study of fluid bed dryers in a bid to make proper operation of the equipment easier and clearer.